Peakdale Molecular (part of the Concept Life Sciences Group) is a leading UK-based provider of drug discovery services to the pharmaceutical, biotech, diagnostics and materials sciences.
As a company, we have a single aim: to accelerate our customers’ discovery initiatives through innovation.
By applying our renowned skills for problem-solving, and open communications, Peakdale scientists pride themselves in seizing the initiative, providing energy, skill and creativity toward the project objectives.
Peakdale Molecular operates on two sites, from our headquarters in the Peak District and at Discovery Park located at Sandwich, Kent.
Our range of speciality services includes:
Drug Discovery Support, Nucleoside Chemistry, Materials Chemistry and Research Support.
In Vitro ADMET, Medicinal Chemistry, Computational Chemistry Services
We place great emphasis on the close interaction between our medicinal chemists, our Computational Chemistry department, our Synthetic Chemistry, and our in vitro ADMET department.
Nucleoside, Nucleotide and Carbohydrate Chemistry.
Peakdale Molecular has particular expertise in the specialist chemistry, purification and analytical techniques required to synthesise these challenging compounds.
Printable Electronics, Nanomaterials, Performance Lubricants & Fuel Additives
In recent years, Peakdale Molecular has rapidly developed experience and expertise in synthetic chemistry for high value materials, and has invested in state-of-the-art equipment to enable materials science projects.
PR&D, Analytical & Purification, Pressure & Hydrogenation Chemistry, Catalogue
Peakdale is able to fully support your research program with experienced scientists and specialist services. All services are available individually (on a Fee For Service basis) or as part of a fully integrated research project (utilising dedicated Full-Time Equivalent scientists).
Customised Assay Design, Highly Repoducible Data and Direct Communications.
At Peakdale Molecular our range of in vitro ADMET models delivers high quality, accurate and reproducible data. With efficient turnaround times, we help accelerate our customers’ drug discovery programmes. In addition to our core assays, we offer clients the option of customised assay design within a completely confidential service.
Peakdale Molecular’s COO Dr Paul Doyle Invited to Judge EDT Industry Leaders Awards 2016
Every year the EDT (Engineering development Trust) hosts the Future Industry Leaders Awards and, this year, Dr Paul Doyle, COO of Peakdale Molecular and CSO of Concept Life Sciences was invited to be on the judging panel for the North West finals. The EDT delivers over 30,000 STEM (science, technology, engineering and mathematics) experiences each […]
Peakdale Adds Two New Team Members to Further Extend its Biological Offering
In order to further extend its biology and integrated drug discovery offering Peakdale Molecular Limited has added two new members to its team. Christopher Doe, PhD, joins as Head of Biology and Sascha Hartmann has joined the business development team as Business Development Manager – Biology Services. Chris, who will be based at Discovery Park […]
Centauri Therapeutics extends research partnership with Peakdale Molecular
Peakdale Molecular Limited, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries has signed an agreement to extend its research collaboration with Centauri Therapeutics, a UK based biotechnology company focussed on the discovery and development of novel molecules targeting life threatening diseases. Peakdale provides synthetic and analytical chemistry expertise for the […]
Peakdale COO Judges the Business Awards North West Regional Finals 2016
Our Chief Operating Officer, Dr Paul Doyle has been especially selected to judge entries at the YINI-EDT Business Awards North West Regional Finals 2016. The Future Industry Leaders Awards, formerly known as The Contribution to the Business Awards, is a great opportunity for students to showcase their placement projects. Through a short presentation to a […]
Coming Soon: Webinar No.5 – Stable-Isotope Labelled Compounds; Synthesis and Applications
Date & Time: TBA We are pleased to announce for our fifth webinar where we will be looking at Stable-Isotope Labelled Compounds and their possible applications, we look forward to sharing our know-how and experience around this interesting and diverse subject. Although registration is not yet open, send us a quick message and we’ll add you […]
Concept Life Sciences Groups Expands Its Services to the US
The Concept Life Sciences Group, a group created following the acquisition of Peakdale Molecular Limited, Scientific Analysis Laboratories Limited and Resource & Environmental Consultants Limited, has launched its services in the US. The integrated group, which further expanded following the acquisition of CXR Biosciences and Agenda1 Analytical Services in 2015, offers a comprehensive range of […]
2016 FCG Postgraduate Event Scotland
The Scotland section meeting of the annual SCI Postgraduate Symposium took place at the University of St. Andrews on Tuesday 12 April 2016. An audience of over 70 attended the meeting and they were treated to ten talks by speakers from five universities; Edinburgh, Heriot-Watt, Glasgow, Strathclyde and St. Andrews. The talks contained science […]
Concept Life Sciences Group Event Success: Early Safety and Enhancing the Discovery Process Spotlight, London, UK
Peakdale Molecular and CXR Biosciences (members of the Concept Life Sciences Group) brought together a number of eminent speakers recently as part of their Spotlight Session series. The event, which was held at the Kohn Centre at the Royal Society in London focussed on current challenges in integrating safety testing into early drug, agrochemical and […]
Peakdale Hosts ECHONET Training Day
On Friday 15th April Peakdale will host the next ECHONET training day at their Chapel-en-le-Frith Headquarters. During this 1 day event, Peakdale will host a number of workshop classes, geared towards medicinal chemistry. A mixture of hands-on modules and theoretical seminars will give researchers attending the day an introduction to the basic aspects and current developments in medicinal chemistry. […]
Peakdale host: 4th SYNTHESIS IN DRUG DISCOVERY AND DEVELOPMENT symposium
SYNTHESIS IN DRUG DISCOVERY AND DEVELOPMENT 4TH SYMPOSIUM Following on from our hugely successful first symposium in Manchester (2010), symposium in Sheffield (2012) and Leeds (2014) we are pleased to announce the details of our 4th ‘Synthesis in Drug Discovery and Development’ Symposium. TUESDAY 18TH OCTOBER 2016 – THE EDEN BUILDING, LIVERPOOL HOPE UNIVERSITY Following on […]